JPS649932A - Soft capsule preparation using newly combined component as the base - Google Patents

Soft capsule preparation using newly combined component as the base

Info

Publication number
JPS649932A
JPS649932A JP62164145A JP16414587A JPS649932A JP S649932 A JPS649932 A JP S649932A JP 62164145 A JP62164145 A JP 62164145A JP 16414587 A JP16414587 A JP 16414587A JP S649932 A JPS649932 A JP S649932A
Authority
JP
Japan
Prior art keywords
base material
cap
soft capsule
base
capsules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP62164145A
Other languages
Japanese (ja)
Inventor
Masahito Takahashi
Hiroyuki Mochizuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TOYO CAPSEL KK
TOYO KAPUSERU KK
Original Assignee
TOYO CAPSEL KK
TOYO KAPUSERU KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TOYO CAPSEL KK, TOYO KAPUSERU KK filed Critical TOYO CAPSEL KK
Priority to JP62164145A priority Critical patent/JPS649932A/en
Publication of JPS649932A publication Critical patent/JPS649932A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

PURPOSE:To provide enteric soft capsules of high efficiency easily by using a base material consisting of polyethylene glycol (PG), cellulose acetate propionate (CAP) or hydroxypropyl methyl cellulose phthalate (HP). CONSTITUTION:The base material is prepared by admixing CAP or HP to PG and its equivalent substance such as squalene at a PG/CAP weight ratio of (70-97):(30-3). The base material is combined with a soft capsule drug to give the subject preparation. The base material according to the present invention is a clear liquid which is a little viscous at room temperature, and becomes a white and opaque solid, and insoluble, when meets water. The soft capsules can be obtained through a simple process in no need of coating such as in case of tablets, even when enteric or gradually releasing capsules are produced.
JP62164145A 1987-07-01 1987-07-01 Soft capsule preparation using newly combined component as the base Pending JPS649932A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP62164145A JPS649932A (en) 1987-07-01 1987-07-01 Soft capsule preparation using newly combined component as the base

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62164145A JPS649932A (en) 1987-07-01 1987-07-01 Soft capsule preparation using newly combined component as the base

Publications (1)

Publication Number Publication Date
JPS649932A true JPS649932A (en) 1989-01-13

Family

ID=15787603

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62164145A Pending JPS649932A (en) 1987-07-01 1987-07-01 Soft capsule preparation using newly combined component as the base

Country Status (1)

Country Link
JP (1) JPS649932A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994000128A1 (en) * 1992-06-22 1994-01-06 Lunar Corporation ORAL 1α-HYDROXYPREVITAMIN D
WO1994014421A3 (en) * 1992-12-23 1994-08-18 Diolaiti Luigi Process for preparing controlled release pharmaceutical forms and the forms thus obtained
WO1995011024A1 (en) * 1993-10-19 1995-04-27 The Procter & Gamble Company Picosulphate dosage form
JPWO2003072085A1 (en) * 2002-02-27 2005-06-16 塩野義製薬株式会社 Solid formulation with improved absorption of poorly water-soluble drugs
JP2005531531A (en) * 2002-04-15 2005-10-20 パリス，ローレンス Liquid compositions for sustained-release soft capsules and methods for producing them
EP1940365A2 (en) * 2005-10-24 2008-07-09 Eastman Chemical Company Liquid dosage forms having enteric properties of delayed and then sustained release
JP2011057712A (en) * 1998-11-04 2011-03-24 Mayne Pharma Plc Oral administration of adenosine analogue

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994000128A1 (en) * 1992-06-22 1994-01-06 Lunar Corporation ORAL 1α-HYDROXYPREVITAMIN D
WO1994014421A3 (en) * 1992-12-23 1994-08-18 Diolaiti Luigi Process for preparing controlled release pharmaceutical forms and the forms thus obtained
US5662935A (en) * 1992-12-23 1997-09-02 Saitec S.R.L. Process for preparing controlled release pharmaceutical forms and the forms thus obtained
WO1995011024A1 (en) * 1993-10-19 1995-04-27 The Procter & Gamble Company Picosulphate dosage form
US5631022A (en) * 1993-10-19 1997-05-20 The Procter & Gamble Company Picosulfate dosage form
JP2011057712A (en) * 1998-11-04 2011-03-24 Mayne Pharma Plc Oral administration of adenosine analogue
JPWO2003072085A1 (en) * 2002-02-27 2005-06-16 塩野義製薬株式会社 Solid formulation with improved absorption of poorly water-soluble drugs
JP2005531531A (en) * 2002-04-15 2005-10-20 パリス，ローレンス Liquid compositions for sustained-release soft capsules and methods for producing them
JP4918212B2 (en) * 2002-04-15 2012-04-18 パリス，ローレンス Liquid compositions for sustained-release soft capsules and methods for producing them
EP1940365A2 (en) * 2005-10-24 2008-07-09 Eastman Chemical Company Liquid dosage forms having enteric properties of delayed and then sustained release
JP2009512699A (en) * 2005-10-24 2009-03-26 イーストマン ケミカル カンパニー Liquid dosage form with enteric properties of delayed release followed by sustained release

Similar Documents

Publication Publication Date Title
KR840000228A (en) Method for preparing dry powder in preparation mixture
DK0649651T3 (en) Preparation of soft gelatin capsules
KR910014120A (en) Oral Pharmaceutical Formulations of Fimovevenan
CA2168732A1 (en) Gelatin Capsules Containing a Highly Concentrated Acetaminophen Solution
NO308828B1 (en) Pharmaceutical preparation
EP0121321A3 (en) Pharmaceutical compositions
IL65706A (en) Slow release pharmaceutical composition comprising indoramin and its preparation
NO146456C (en) PROCEDURE FOR THE PREPARATION OF Capsule Drugs, Especially For Medication Dosage Capsule
RU99108461A (en) DOSAGE FORM FOR ORAL ADMINISTRATION WITH DELAYED IMMEDIATE RELEASE AND METHOD FOR PREPARING IT
UA13038A1 (en) METHOD OF OBTAINING TABLETS
DK0934058T3 (en) Stable drug form with benzimidazole derivatives as active substance for oral administration and method of preparation thereof
IL56991A (en) 4-halo-3-oxoandrost-4-ene-17 beta-thiocarboxylic acid esters,their preparation and pharmaceutical compositions containing them
JPS5770814A (en) Oral preparation of blood clotting eighth factor
NO874989L (en) PROCEDURE FOR THE PREPARATION OF TABLETS OR CAPSULES CONTAINING A SUPER DESINT Migrant.
JPS649932A (en) Soft capsule preparation using newly combined component as the base
IE36611B1 (en) Propanolamine derivatives their preparation and therapeutic compositions containing the same
IL47205A0 (en) Watersoluble extracts,their preparation and pharmaceutical compositions containing them
ZA792283B (en) Structural analogs of natural glycerides,process for their preparation and pharmaceutical compositions thereof
JPS5442380A (en) Regenerative capsule
ATE21336T1 (en) GALENIC FORM FOR ORAL ADMINISTRATION AND PROCESS FOR THE PREPARATION THEREOF.
IL46539A0 (en) Esters of dihydroapovincaminic acid,their preparation and pharmaceutical compositions containing them
EP0276116A3 (en) Capsule filling
IL47268A (en) Racemic or optically active 4-acyl-1,3,4,5-tetrahydro-2h-1,4-benzo-diazepin-2-ones,process for their preparation and pharmaceutical compositions containing them
IL47207A0 (en) Watersoluble extracts,their preparation and pharmaceutical compositions containing them
JPS52130905A (en) Medicinal composition